| UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: 3235-0582 |
| Expires: March 31, 2021 |
| Estimated average burden |
| hours per response........7.2 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 06565
Tekla Healthcare Opportunites Fund
(Exact name of registrant as specified in charter)
100 Federal Street, 19th Floor, Boston, MA | | 02110 |
(Address of principal executive offices) | | (Zip code) |
Laura Woodward
Tekla Healthcare Opportunities Fund
100 Federal Street, 19th Floor, Boston MA 02110
(Name and address of agent for service)
Registrant’s telephone number, including area code: 617-772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/17-6/30/18
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
THQ Vote Summary
ABBOTT LABORATORIES
Security | 002824100 | Meeting Type | Annual |
Ticker Symbol | ABT | Meeting Date | 27-Apr-2018 |
Record Date | 28-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | R.J. Alpern | | | | For | | For | |
| | 2 | R.S. Austin | | | | For | | For | |
| | 3 | S.E. Blount | | | | For | | For | |
| | 4 | E.M. Liddy | | | | For | | For | |
| | 5 | N. McKinstry | | | | For | | For | |
| | 6 | P.N. Novakovic | | | | For | | For | |
| | 7 | W.A. Osborn | | | | For | | For | |
| | 8 | S.C. Scott III | | | | For | | For | |
| | 9 | D.J. Starks | | | | For | | For | |
| | 10 | J.G. Stratton | | | | For | | For | |
| | 11 | G.F. Tilton | | | | For | | For | |
| | 12 | M.D. White | | | | For | | For | |
2. | | Ratification of Ernst & Young LLP as Auditors | | Management | | For | | For | |
3. | | Say on Pay - An Advisory Vote to Approve Executive Compensation | | Management | | For | | For | |
4. | | Shareholder Proposal - Independent Board Chairman | | Shareholder | | For | | Against | |
ABBVIE INC.
Security | 00287Y109 | Meeting Type | Annual |
Ticker Symbol | ABBV | Meeting Date | 04-May-2018 |
Record Date | 07-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Roxanne S. Austin | | | | For | | For | |
| | 2 | Richard A. Gonzalez | | | | For | | For | |
| | 3 | Rebecca B. Roberts | | | | For | | For | |
| | 4 | Glenn F. Tilton | | | | For | | For | |
2. | | Ratification of Ernst & Young LLP as AbbVie’s independent registered public accounting firm for 2018 | | Management | | For | | For | |
3. | | Say on Pay - An advisory vote on the approval of executive compensation | | Management | | For | | For | |
4. | | Say When on Pay - An advisory vote on the frequency of the advisory vote to approve executive compensation | | Management | | 1 Year | | For | |
5. | | Approval of a management proposal regarding amendment of the certificate of incorporation for the annual election of directors | | Management | | For | | For | |
6. | | Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting | | Management | | For | | For | |
7. | | Stockholder Proposal - to Issue an Annual Report on Lobbying | | Shareholder | | Against | | For | |
8. | | Stockholder Proposal - to Separate Chair and CEO | | Shareholder | | For | | Against | |
9. | | Stockholder Proposal - to Issue an Annual Compensation Committee Report on Drug Pricing | | Shareholder | | Against | | For | |
ACADIA HEALTHCARE COMPANY, INC.
Security | 00404A109 | Meeting Type | Annual |
Ticker Symbol | ACHC | Meeting Date | 03-May-2018 |
Record Date | 09-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Director: E. Perot Bissell | | Management | | For | | For | |
1.2 | | Election of Director: Vicky B. Gregg | | Management | | For | | For | |
2. | | Advisory vote on the compensation of the Company’s named executive officers as presented in the Proxy Statement. | | Management | | For | | For | |
3. | | Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
AETNA INC.
Security | 00817Y108 | Meeting Type | Special |
Ticker Symbol | AET | Meeting Date | 13-Mar-2018 |
Record Date | 05-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | To approve and adopt the Agreement and Plan of Merger, dated as of December 3, 2017, as it may be amended from time to time, among CVS Health Corporation, Hudson Merger Sub Corp. and Aetna Inc. (the “merger agreement”). | | Management | | For | | For | |
2. | | To approve the adjournment from time to time of the Special Meeting of Shareholders of Aetna Inc. if necessary to solicit additional proxies if there are not sufficient votes to approve and adopt the merger agreement at the time of the Special Meeting of Shareholders of Aetna Inc. or any adjournment or postponement thereof. | | Management | | For | | For | |
3. | | To approve, on an advisory (non-binding) basis, the compensation that will or may be paid or provided by Aetna Inc. to its named executive officers in connection with the merger of Hudson Merger Sub Corp. with and into Aetna Inc. | | Management | | For | | For | |
AETNA INC.
Security | 00817Y108 | Meeting Type | Annual |
Ticker Symbol | AET | Meeting Date | 18-May-2018 |
Record Date | 16-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Fernando Aguirre | | Management | | For | | For | |
1b. | | Election of Director: Mark T. Bertolini | | Management | | For | | For | |
1c. | | Election of Director: Frank M. Clark | | Management | | For | | For | |
1d. | | Election of Director: Molly J. Coye, M.D. | | Management | | For | | For | |
1e. | | Election of Director: Roger N. Farah | | Management | | For | | For | |
1f. | | Election of Director: Jeffrey E. Garten | | Management | | For | | For | |
1g. | | Election of Director: Ellen M. Hancock | | Management | | For | | For | |
1h. | | Election of Director: Richard J. Harrington | | Management | | For | | For | |
1i. | | Election of Director: Edward J. Ludwig | | Management | | For | | For | |
1j. | | Election of Director: Olympia J. Snowe | | Management | | For | | For | |
2. | | Company Proposal - Approval of the Appointment of the Independent Registered Public Accounting Firm for 2018 | | Management | | For | | For | |
3. | | Company Proposal - Approval of the Company’s Executive Compensation on a Non-Binding Advisory Basis | | Management | | For | | For | |
4A. | | Shareholder Proposal - Annual Report on Direct and Indirect Lobbying | | Shareholder | | Against | | For | |
4B. | | Shareholder Proposal - Special Shareholder Meeting Vote Threshold | | Shareholder | | Against | | For | |
ALEXION PHARMACEUTICALS, INC.
Security | 015351109 | Meeting Type | Annual |
Ticker Symbol | ALXN | Meeting Date | 08-May-2018 |
Record Date | 12-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Felix J. Baker | | | | For | | For | |
| | 2 | David R. Brennan | | | | For | | For | |
| | 3 | Christopher J. Coughlin | | | | For | | For | |
| | 4 | Deborah Dunsire | | | | For | | For | |
| | 5 | Paul A. Friedman | | | | For | | For | |
| | 6 | Ludwig N. Hantson | | | | For | | For | |
| | 7 | John T. Mollen | | | | For | | For | |
| | 8 | Francois Nader | | | | For | | For | |
| | 9 | Judith A. Reinsdorf | | | | For | | For | |
| | 10 | Andreas Rummelt | | | | For | | For | |
2. | | Ratification of appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm. | | Management | | For | | For | |
3. | | Approval of a non-binding advisory vote of the 2017 compensation paid to Alexion’s named executive officers. | | Management | | For | | For | |
4. | | To request the Board to require an independent Chairman. | | Shareholder | | For | | Against | |
ALLERGAN PLC
Security | G0177J108 | Meeting Type | Annual |
Ticker Symbol | AGN | Meeting Date | 02-May-2018 |
Record Date | 06-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Nesli Basgoz, M.D. | | Management | | For | | For | |
1b. | | Election of Director: Paul M. Bisaro | | Management | | For | | For | |
1c. | | Election of Director: Joseph H. Boccuzi | | Management | | For | | For | |
1d. | | Election of Director: Christopher W. Bodine | | Management | | For | | For | |
1e. | | Election of Director: Adriane M. Brown | | Management | | For | | For | |
1f. | | Election of Director: Christopher J. Coughlin | | Management | | For | | For | |
1g. | | Election of Director: Carol Anthony (John) Davidson | | Management | | For | | For | |
1h. | | Election of Director: Catherine M. Klema | | Management | | For | | For | |
1i. | | Election of Director: Peter J. McDonnell, M.D. | | Management | | For | | For | |
1j. | | Election of Director: Patrick J. O’Sullivan | | Management | | For | | For | |
1k. | | Election of Director: Brenton L. Saunders | | Management | | For | | For | |
1l. | | Election of Director: Fred G. Weiss | | Management | | For | | For | |
2. | | To approve, in a non-binding vote, Named Executive Officer compensation. | | Management | | For | | For | |
3. | | To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for the fiscal year ending December 31, 2018 and to authorize, in a binding vote, the Board of Directors, acting through its Audit and Compliance Committee, to determine PricewaterhouseCoopers LLP’s remuneration. | | Management | | For | | For | |
4. | | To renew the authority of the directors of the Company (the “Directors”) to issue shares. | | Management | | For | | For | |
5A. | | To renew the authority of the Directors to issue shares for cash without first offering shares to existing shareholders. | | Management | | For | | For | |
5B. | | To authorize the Directors to allot new shares up to an additional 5% for cash in connection with an acquisition or other capital investment. | | Management | | For | | For | |
6. | | To consider a shareholder proposal requiring an independent Board Chairman, if properly presented at the meeting. | | Shareholder | | Against | | For | |
AMERISOURCEBERGEN CORPORATION
Security | 03073E105 | Meeting Type | Annual |
Ticker Symbol | ABC | Meeting Date | 01-Mar-2018 |
Record Date | 02-Jan-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Ornella Barra | | Management | | For | | For | |
1B. | | Election of Director: Steven H. Collis | | Management | | For | | For | |
1C. | | Election of Director: Douglas R. Conant | | Management | | For | | For | |
1D. | | Election of Director: D. Mark Durcan | | Management | | For | | For | |
1E. | | Election of Director: Richard W. Gochnauer | | Management | | For | | For | |
1F. | | Election of Director: Lon R. Greenberg | | Management | | For | | For | |
1G. | | Election of Director: Jane E. Henney, M.D. | | Management | | For | | For | |
1H. | | Election of Director: Kathleen W. Hyle | | Management | | For | | For | |
1I. | | Election of Director: Michael J. Long | | Management | | For | | For | |
1J. | | Election of Director: Henry W. McGee | | Management | | For | | For | |
2. | | Ratification of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2018. | | Management | | For | | For | |
3. | | Advisory vote to approve the compensation of our named executive officers. | | Management | | For | | For | |
4. | | Approval of an amendment and restatement of the AmerisourceBergen Corporation 2011 Employee Stock Purchase Plan. | | Management | | For | | For | |
5. | | Stockholder proposal, if properly presented, to urge the Board of Directors to adopt a policy that the Chairman of the Board be an independent director. | | Shareholder | | Against | | For | |
6. | | Stockholder proposal, if properly presented, regarding the ownership threshold for calling special meetings of stockholders. | | Shareholder | | Against | | For | |
7. | | Stockholder proposal, if properly presented, to urge the Board of Directors to adopt a policy to disclose certain incentive compensation clawbacks. | | Shareholder | | Against | | For | |
8. | | Stockholder proposal, if properly presented, to urge the Board of Directors to report to stockholders on governance measures implemented related to opioids. | | Shareholder | | Against | | For | |
AMGEN INC.
Security | 031162100 | Meeting Type | Annual |
Ticker Symbol | AMGN | Meeting Date | 22-May-2018 |
Record Date | 23-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Dr. Wanda M. Austin | | Management | | For | | For | |
1b. | | Election of Director: Mr. Robert A. Bradway | | Management | | For | | For | |
1c. | | Election of Director: Dr. Brian J. Druker | | Management | | For | | For | |
1d. | | Election of Director: Mr. Robert A. Eckert | | Management | | For | | For | |
1e. | | Election of Director: Mr. Greg C. Garland | | Management | | For | | For | |
1f. | | Election of Director: Mr. Fred Hassan | | Management | | For | | For | |
1g. | | Election of Director: Dr. Rebecca M. Henderson | | Management | | For | | For | |
1h. | | Election of Director: Mr. Frank C. Herringer | | Management | | For | | For | |
1i. | | Election of Director: Mr. Charles M. Holley, Jr. | | Management | | For | | For | |
1j. | | Election of Director: Dr. Tyler Jacks | | Management | | For | | For | |
1k. | | Election of Director: Ms. Ellen J. Kullman | | Management | | For | | For | |
1l. | | Election of Director: Dr. Ronald D. Sugar | | Management | | For | | For | |
1m. | | Election of Director: Dr. R. Sanders Williams | | Management | | For | | For | |
2. | | Advisory vote to approve our executive compensation. | | Management | | For | | For | |
3. | | To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
4. | | Stockholder proposal for an annual report on the extent to which risks related to public concern over drug pricing strategies are integrated into our executive incentive compensation. | | Shareholder | | Against | | For | |
AMICUS THERAPEUTICS, INC.
Security | 03152W109 | Meeting Type | Annual |
Ticker Symbol | FOLD | Meeting Date | 07-Jun-2018 |
Record Date | 16-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Donald J. Hayden, Jr. | | | | For | | For | |
| | 2 | Craig Wheeler | | | | For | | For | |
2. | | Proposal to approve an amendment to our Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01 per share, that we are authorized to issue from 250,000,000 to 500,000,000 | | Management | | For | | For | |
3. | | Approval of the Amended and Restated 2007 Equity Incentive Plan to add 5,000,000 shares to the equity pool | | Management | | For | | For | |
4. | | Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018 | | Management | | For | | For | |
5. | | Approval, on an advisory basis, the Company’s executive compensation | | Management | | For | | For | |
ANTHEM, INC.
Security | 036752103 | Meeting Type | Annual |
Ticker Symbol | ANTM | Meeting Date | 16-May-2018 |
Record Date | 09-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Lewis Hay, III | | Management | | For | | For | |
1b. | | Election of Director: Julie A. Hill | | Management | | For | | For | |
1c. | | Election of Director: Antonio F. Neri | | Management | | For | | For | |
1d. | | Election of Director: Ramiro G. Peru | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2018. | | Management | | For | | For | |
3. | | Advisory vote to approve the compensation of our named executive officers. | | Management | | For | | For | |
4. | | To approve proposed amendments to our Articles of Incorporation to allow shareholders owning 20% or more of our common stock to call special meetings of shareholders. | | Management | | For | | For | |
5. | | Shareholder proposal to allow shareholders owning 10% or more of our common stock to call special meetings of shareholders. | | Shareholder | | Against | | For | |
BAXTER INTERNATIONAL INC.
Security | 071813109 | Meeting Type | Annual |
Ticker Symbol | BAX | Meeting Date | 08-May-2018 |
Record Date | 15-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Jose (Joe) E. Almeida | | Management | | For | | For | |
1b. | | Election of Director: Thomas F. Chen | | Management | | For | | For | |
1c. | | Election of Director: John D. Forsyth | | Management | | For | | For | |
1d. | | Election of Director: James R. Gavin III | | Management | | For | | For | |
1e. | | Election of Director: Peter S. Hellman | | Management | | For | | For | |
1f. | | Election of Director: Munib Islam | | Management | | For | | For | |
1g. | | Election of Director: Michael F. Mahoney | | Management | | For | | For | |
1h. | | Election of Director: Stephen N. Oesterle | | Management | | For | | For | |
1i. | | Election of Director: Carole J. Shapazian | | Management | | For | | For | |
1j. | | Election of Director: Cathy R. Smith | | Management | | For | | For | |
1k. | | Election of Director: Thomas T. Stallkamp | | Management | | For | | For | |
1l. | | Election of Director: Albert P.L. Stroucken | | Management | | For | | For | |
2. | | Advisory Vote to Approve Named Executive Officer Compensation | | Management | | For | | For | |
3. | | Ratification of Appointment of Independent Registered Public Accounting Firm | | Management | | For | | For | |
4. | | Stockholder Proposal - Independent Board Chairman | | Shareholder | | Against | | For | |
5. | | Stockholder Proposal- Right to Act by Written Consent | | Shareholder | | Against | | For | |
BIOCLIN THERAPEUTICS, INC.
Security | N/A | Meeting Type | Written Consent |
Ticker Symbol | N/A | Meeting Date | 27-Sep-2017 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Election of Director | | Management | | For | | For | |
2. | | General Authorizing Resolution | | Management | | For | | For | |
BIOCLIN THERAPEUTICS, INC.
Security | N/A | Meeting Type | Written Consent |
Ticker Symbol | N/A | Meeting Date | 24-Apr-2018 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Amendment and Restatement of Restated Certificate of Incorporation | | Management | | For | | For | |
2. | | Series B Preferred Stock Financing | | Management | | For | | For | |
3. | | Waiver of Preemptive Rights | | Management | | For | | For | |
4. | | Notice of Interested Party Transactions | | Management | | For | | For | |
5. | | Amendment of 2013 Stock and Option Grant Plan | | Management | | For | | For | |
6. | | General Authorizing Resolution | | Management | | For | | For | |
BIOCLIN THERAPEUTICS, INC.
Security | N/A | Meeting Type | Written Consent |
Ticker Symbol | N/A | Meeting Date | 21-May-2018 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Election of Director | | Management | | For | | For | |
2. | | General Authorizing Resolution | | Management | | For | | For | |
BIOGEN INC.
Security | 09062X103 | Meeting Type | Annual |
Ticker Symbol | BIIB | Meeting Date | 12-Jun-2018 |
Record Date | 17-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Alexander J. Denner | | Management | | For | | For | |
1b. | | Election of Director: Caroline D. Dorsa | | Management | | For | | For | |
1c. | | Election of Director: Nancy L. Leaming | | Management | | For | | For | |
1d. | | Election of Director: Richard C. Mulligan | | Management | | For | | For | |
1e. | | Election of Director: Robert W. Pangia | | Management | | For | | For | |
1f. | | Election of Director: Stelios Papadopoulos | | Management | | For | | For | |
1g. | | Election of Director: Brian S. Posner | | Management | | For | | For | |
1h. | | Election of Director: Eric K. Rowinsky | | Management | | For | | For | |
1i. | | Election of Director: Lynn Schenk | | Management | | For | | For | |
1j. | | Election of Director: Stephen A. Sherwin | | Management | | For | | For | |
1k. | | Election of Director: Michel Vounatsos | | Management | | For | | For | |
2. | | To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | Say on Pay - To approve an advisory vote on executive compensation. | | Management | | For | | For | |
4. | | Stockholder proposal requesting certain proxy access bylaw amendments. | | Shareholder | | Against | | For | |
5. | | Stockholder proposal requesting a report on the extent to which risks related to public concern over drug pricing strategies are integrated into incentive compensation arrangements. | | Shareholder | | Against | | For | |
BIOHAVEN PHARMACEUTICAL HLDG CO LTD
Security | G11196105 | Meeting Type | Annual |
Ticker Symbol | BHVN | Meeting Date | 01-May-2018 |
Record Date | 26-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Dr. Eric I. Aguiar | | Management | | For | | For | |
1B. | | Election of Director: Dr. Albert Cha | | Management | | For | | For | |
1C. | | Election of Director: Ms. Julia P. Gregory | | Management | | For | | For | |
2. | | Ratification of appointment of PricewaterhouseCoopers LLP as independent auditors for fiscal year 2018. | | Management | | For | | For | |
BOSTON SCIENTIFIC CORPORATION
Security | 101137107 | Meeting Type | Annual |
Ticker Symbol | BSX | Meeting Date | 10-May-2018 |
Record Date | 16-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Nelda J. Connors | | Management | | For | | For | |
1b. | | Election of Director: Charles J. Dockendorff | | Management | | For | | For | |
1c. | | Election of Director: Yoshiaki Fujimori | | Management | | For | | For | |
1d. | | Election of Director: Donna A. James | | Management | | For | | For | |
1e. | | Election of Director: Edward J. Ludwig | | Management | | For | | For | |
1f. | | Election of Director: Stephen P. MacMillan | | Management | | For | | For | |
1g. | | Election of Director: Michael F. Mahoney | | Management | | For | | For | |
1h. | | Election of Director: David J. Roux | | Management | | For | | For | |
1i. | | Election of Director: John E. Sununu | | Management | | For | | For | |
1j. | | Election of Director: Ellen M. Zane | | Management | | For | | For | |
2. | | To approve, on a non-binding, advisory basis, named executive officer compensation. | | Management | | For | | For | |
3. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2018 fiscal year. | | Management | | For | | For | |
BRISTOL-MYERS SQUIBB COMPANY
Security | 110122108 | Meeting Type | Annual |
Ticker Symbol | BMY | Meeting Date | 01-May-2018 |
Record Date | 14-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: P. J. Arduini | | Management | | For | | For | |
1B. | | Election of Director: J. Baselga, M.D., Ph.D. | | Management | | For | | For | |
1C. | | Election of Director: R. J. Bertolini | | Management | | For | | For | |
1D. | | Election of Director: G. Caforio, M.D. | | Management | | For | | For | |
1E. | | Election of Director: M. W. Emmens | | Management | | For | | For | |
1F. | | Election of Director: M. Grobstein | | Management | | For | | For | |
1G. | | Election of Director: A. J. Lacy | | Management | | For | | For | |
1H. | | Election of Director: D. C. Paliwal | | Management | | For | | For | |
1I. | | Election of Director: T. R. Samuels | | Management | | For | | For | |
1J. | | Election of Director: G. L. Storch | | Management | | For | | For | |
1K. | | Election of Director: V. L. Sato, Ph.D. | | Management | | For | | For | |
1L. | | Election of Director: K. H. Vousden, Ph.D. | | Management | | For | | For | |
2. | | Advisory vote to approve the compensation of our Named Executive Officers | | Management | | For | | For | |
3. | | Ratification of the appointment of an independent registered public accounting firm | | Management | | For | | For | |
4. | | Shareholder Proposal on Annual Report Disclosing How Risks Related to Public Concern Over Drug Pricing Strategies are Incorporated into Incentive Compensation Plans | | Shareholder | | Against | | For | |
5. | | Shareholder Proposal to Lower the Share Ownership Threshold to Call Special Shareholder Meetings | | Shareholder | | Against | | For | |
CELGENE CORPORATION
Security | 151020104 | Meeting Type | Annual |
Ticker Symbol | CELG | Meeting Date | 13-Jun-2018 |
Record Date | 19-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Mark J. Alles | | | | For | | For | |
| | 2 | R W Barker, D.Phil, OBE | | | | For | | For | |
| | 3 | Hans E. Bishop | | | | For | | For | |
| | 4 | Michael W. Bonney | | | | For | | For | |
| | 5 | Michael D. Casey | | | | For | | For | |
| | 6 | Carrie S. Cox | | | | For | | For | |
| | 7 | Michael A. Friedman, MD | | | | For | | For | |
| | 8 | Julia A. Haller, M.D. | | | | For | | For | |
| | 9 | P. A. Hemingway Hall | | | | For | | For | |
| | 10 | James J. Loughlin | | | | For | | For | |
| | 11 | Ernest Mario, Ph.D. | | | | For | | For | |
| | 12 | John H. Weiland | | | | For | | For | |
2. | | Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | Approval, by non-binding vote, of executive compensation of the Company’s named executive officers. | | Management | | For | | For | |
4. | | Advisory vote on stockholder proposal to request the Company’s Board of Directors to amend the Company’s proxy access by-law provision to eliminate the limit on the number of stockholders that can aggregate their shares to achieve the holding requirement for nomination of directors, described in more detail in the proxy statement. | | Shareholder | | Against | | For | |
5. | | Advisory vote on stockholder proposal to request the Company’s Board of Directors to adopt a policy and amend the Company’s governing documents to require that the Chairman of the Board be an independent member, described in more detail in the proxy statement. | | Shareholder | | For | | Against | |
CENTENE CORPORATION
Security | 15135B101 | Meeting Type | Annual |
Ticker Symbol | CNC | Meeting Date | 24-Apr-2018 |
Record Date | 23-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Jessica L. Blume | | Management | | For | | For | |
1B. | | Election of Director: Frederick H. Eppinger | | Management | | For | | For | |
1C. | | Election of Director: David L. Steward | | Management | | For | | For | |
2. | | ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION. | | Management | | For | | For | |
3. | | RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2018. | | Management | | For | | For | |
CHARLES RIVER LABORATORIES INTL., INC.
Security | 159864107 | Meeting Type | Annual |
Ticker Symbol | CRL | Meeting Date | 08-May-2018 |
Record Date | 12-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: James C. Foster | | Management | | For | | For | |
1B. | | Election of Director: Robert J. Bertolini | | Management | | For | | For | |
1C. | | Election of Director: Stephen D. Chubb | | Management | | For | | For | |
1D. | | Election of Director: Deborah T. Kochevar | | Management | | For | | For | |
1E. | | Election of Director: Martin W. MacKay | | Management | | For | | For | |
1F. | | Election of Director: Jean-Paul Mangeolle | | Management | | For | | For | |
1G. | | Election of Director: George E. Massaro | | Management | | For | | For | |
1H. | | Election of Director: George M. Milne, Jr. | | Management | | For | | For | |
1I. | | Election of Director: C. Richard Reese | | Management | | For | | For | |
1J. | | Election of Director: Craig B. Thompson | | Management | | For | | For | |
1K. | | Election of Director: Richard F. Wallman | | Management | | For | | For | |
2. | | Say on Pay - An advisory vote to approve our executive compensation. | | Management | | For | | For | |
3. | | Approval of 2018 Incentive Plan. | | Management | | For | | For | |
4. | | Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accountants for the fiscal year ending December 29, 2018. | | Management | | For | | For | |
CIGNA CORPORATION
Security | 125509109 | Meeting Type | Annual |
Ticker Symbol | CI | Meeting Date | 25-Apr-2018 |
Record Date | 26-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A | | Election of Director: David M. Cordani | | Management | | For | | For | |
1B | | Election of Director: Eric J. Foss | | Management | | For | | For | |
1C | | Election of Director: Isaiah Harris, Jr. | | Management | | For | | For | |
1D | | Election of Director: Roman Martinez IV | | Management | | For | | For | |
1E | | Election of Director: John M. Partridge | | Management | | For | | For | |
1F | | Election of Director: James E. Rogers | | Management | | For | | For | |
1G | | Election of Director: Eric C. Wiseman | | Management | | For | | For | |
1H | | Election of Director: Donna F. Zarcone | | Management | | For | | For | |
1I | | Election of Director: William D. Zollars | | Management | | For | | For | |
2. | | Advisory approval of Cigna’s executive compensation. | | Management | | For | | For | |
3. | | Ratification of appointment of PricewaterhouseCoopers LLP as Cigna’s independent registered public accounting firm for 2018. | | Management | | For | | For | |
4. | | Approval of an amendment to the Company’s Restated Certificate of Incorporation to eliminate the supermajority voting requirement. | | Management | | For | | For | |
COMMUNITY HEALTH SYSTEMS, INC.
Security | 203668108 | Meeting Type | Annual |
Ticker Symbol | CYH | Meeting Date | 15-May-2018 |
Record Date | 19-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: John A. Clerico | | Management | | For | | For | |
1b. | | Election of Director: Michael Dinkins | | Management | | For | | For | |
1c. | | Election of Director: James S. Ely III | | Management | | For | | For | |
1d. | | Election of Director: John A. Fry | | Management | | For | | For | |
1e. | | Election of Director: Tim L. Hingtgen | | Management | | For | | For | |
1f. | | Election of Director: William Norris Jennings, M.D. | | Management | | For | | For | |
1g. | | Election of Director: K. Ranga Krishnan, MBBS | | Management | | For | | For | |
1h. | | Election of Director: Julia B. North | | Management | | For | | For | |
1i. | | Election of Director: Wayne T. Smith | | Management | | For | | For | |
1j. | | Election of Director: H. James Williams, Ph.D. | | Management | | For | | For | |
2. | | Proposal to approve on an advisory (non-binding) basis the compensation of the Company’s named executive officers. | | Management | | For | | For | |
3. | | Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors as of March 14, 2018, subject to stockholder approval. | | Management | | For | | For | |
4. | | Proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
5. | | Stockholder proposal entitled “Clean Energy Resolution.” | | Shareholder | | Against | | For | |
CVS HEALTH CORPORATION
Security | 126650100 | Meeting Type | Special |
Ticker Symbol | CVS | Meeting Date | 13-Mar-2018 |
Record Date | 05-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Stock Issuance Proposal: To approve the issuance of shares of CVS Health Corporation common stock to shareholders of Aetna Inc. in the merger between Aetna Inc. and Hudson Merger Sub Corp., a wholly-owned subsidiary of CVS Health Corporation, pursuant to the terms and conditions of the Agreement and Plan of Merger dated as of December 3, 2017, as it may be amended from time to time, among CVS Health Corporation, Hudson Merger Sub Corp. and Aetna Inc. | | Management | | For | | For | |
2. | | Adjournment Proposal: To approve the adjournment from time to time of the special meeting of stockholders of CVS Health Corporation if necessary to solicit additional proxies if there are not sufficient votes at the time of the special meeting, or any adjournment or postponement thereof, to approve the Stock Issuance Proposal. | | Management | | For | | For | |
CVS HEALTH CORPORATION
Security | 126650100 | Meeting Type | Annual |
Ticker Symbol | CVS | Meeting Date | 04-Jun-2018 |
Record Date | 10-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Richard M. Bracken | | Management | | For | | For | |
1b. | | Election of Director: C. David Brown II | | Management | | For | | For | |
1c. | | Election of Director: Alecia A. DeCoudreaux | | Management | | For | | For | |
1d. | | Election of Director: Nancy-Ann M. DeParle | | Management | | For | | For | |
1e. | | Election of Director: David W. Dorman | | Management | | For | | For | |
1f. | | Election of Director: Anne M. Finucane | | Management | | For | | For | |
1g. | | Election of Director: Larry J. Merlo | | Management | | For | | For | |
1h. | | Election of Director: Jean-Pierre Millon | | Management | | For | | For | |
1i. | | Election of Director: Mary L. Schapiro | | Management | | For | | For | |
1j. | | Election of Director: Richard J. Swift | | Management | | For | | For | |
1k. | | Election of Director: William C. Weldon | | Management | | For | | For | |
1l. | | Election of Director: Tony L. White | | Management | | For | | For | |
2. | | Proposal to ratify appointment of independent registered public accounting firm for 2018. | | Management | | For | | For | |
3. | | Say on Pay - an advisory vote on the approval of executive compensation. | | Management | | For | | For | |
4. | | Proposal to approve an amendment to the Company’s Certificate of Incorporation to reduce the ownership threshold for our stockholders’ right to call special meetings. | | Management | | For | | For | |
5. | | Stockholder proposal regarding executive pay confidential voting. | | Shareholder | | Against | | For | |
DANAHER CORPORATION
Security | 235851102 | Meeting Type | Annual |
Ticker Symbol | DHR | Meeting Date | 08-May-2018 |
Record Date | 12-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Donald J. Ehrlich | | Management | | For | | For | |
1B. | | Election of Director: Linda Hefner Filler | | Management | | For | | For | |
1C. | | Election of Director: Thomas P. Joyce, Jr. | | Management | | For | | For | |
1D. | | Election of Director: Teri List-Stoll | | Management | | For | | For | |
1E. | | Election of Director: Walter G. Lohr, Jr. | | Management | | For | | For | |
1F. | | Election of Director: Mitchell P. Rales | | Management | | For | | For | |
1G. | | Election of Director: Steven M. Rales | | Management | | For | | For | |
1H. | | Election of Director: John T. Schwieters | | Management | | For | | For | |
1I. | | Election of Director: Alan G. Spoon | | Management | | For | | For | |
1J. | | Election of Director: Raymond C. Stevens, Ph.D. | | Management | | For | | For | |
1K. | | Election of Director: Elias A. Zerhouni, M.D. | | Management | | For | | For | |
2. | | To ratify the selection of Ernst & Young LLP as Danaher’s independent registered public accounting firm. | | Management | | For | | For | |
3. | | To approve on an advisory basis the Company’s named executive officer compensation. | | Management | | For | | For | |
4. | | To act upon a shareholder proposal requesting that Danaher reduce shareholder special meeting threshold from 25% to 10%. | | Shareholder | | Against | | For | |
DIPLOMAT PHARMACY, INC.
Security | 25456K101 | Meeting Type | Annual |
Ticker Symbol | DPLO | Meeting Date | 12-Jun-2018 |
Record Date | 18-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | David Dreyer | | | | For | | For | |
| | 2 | Philip R. Hagerman | | | | For | | For | |
| | 3 | Shawn C. Tomasello | | | | For | | For | |
2. | | Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | Advisory approval of named executive officer compensation. | | Management | | For | | For | |
EDWARDS LIFESCIENCES CORPORATION
Security | 28176E108 | Meeting Type | Annual |
Ticker Symbol | EW | Meeting Date | 17-May-2018 |
Record Date | 22-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | ELECTION OF DIRECTOR: Michael A. Mussallem | | Management | | For | | For | |
1b. | | ELECTION OF DIRECTOR: Kieran T. Gallahue | | Management | | For | | For | |
1c. | | ELECTION OF DIRECTOR: Leslie S. Heisz | | Management | | For | | For | |
1d. | | ELECTION OF DIRECTOR: William J. Link, Ph.D. | | Management | | For | | For | |
1e. | | ELECTION OF DIRECTOR: Steven R. Loranger | | Management | | For | | For | |
1f. | | ELECTION OF DIRECTOR: Martha H. Marsh | | Management | | For | | For | |
1g. | | ELECTION OF DIRECTOR: Wesley W. von Schack | | Management | | For | | For | |
1h. | | ELECTION OF DIRECTOR: Nicholas J. Valeriani | | Management | | For | | For | |
2. | | ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS | | Management | | For | | For | |
3. | | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | | Management | | For | | For | |
4. | | ADVISORY VOTE ON A STOCKHOLDER PROPOSAL REGARDING ACTION BY WRITTEN CONSENT | | Shareholder | | Against | | For | |
ELI LILLY AND COMPANY
Security | 532457108 | Meeting Type | Annual |
Ticker Symbol | LLY | Meeting Date | 07-May-2018 |
Record Date | 12-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: K. Baicker | | Management | | For | | For | |
1b. | | Election of Director: J. E. Fyrwald | | Management | | For | | For | |
1c. | | Election of Director: J. Jackson | | Management | | For | | For | |
1d. | | Election of Director: E. R. Marram | | Management | | For | | For | |
1e. | | Election of Director: J. P. Tai | | Management | | For | | For | |
2. | | Approval, by non-binding vote, of the compensation paid to the company’s named executive officers. | | Management | | For | | For | |
3. | | Ratification of Ernst & Young LLP as the principal independent auditor for 2018. | | Management | | For | | For | |
4. | | Approve amendments to the Articles of Incorporation to eliminate the classified board structure. | | Management | | For | | For | |
5. | | Approve amendments to the Articles of Incorporation to eliminate supermajority voting provisions. | | Management | | For | | For | |
6. | | Approve the Amended and Restated 2002 Lilly Stock Plan. | | Management | | For | | For | |
7. | | Shareholder proposal seeking support for the descheduling of cannabis. | | Shareholder | | Against | | For | |
8. | | Shareholder proposal requesting report regarding direct and indirect political contributions. | | Shareholder | | Against | | For | |
9. | | Shareholder proposal requesting report on policies and practices regarding contract animal laboratories. | | Shareholder | | Against | | For | |
10. | | Shareholder proposal requesting report on extent to which risks related to public concern over drug pricing strategies are integrated into incentive compensation arrangements. | | Shareholder | | Against | | For | |
ESPERION THERAPEUTICS INC
Security | 29664W105 | Meeting Type | Annual |
Ticker Symbol | ESPR | Meeting Date | 23-May-2018 |
Record Date | 26-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Class II Director: Jeffrey Berkowitz, J.D. | | Management | | For | | For | |
1b. | | Election of Class II Director: Antonio M. Gotto Jr., M.D., D.Phil. | | Management | | For | | For | |
1c. | | Election of Class II Director: Nicole Vitullo | | Management | | For | | For | |
2. | | To approve the advisory resolution on the compensation of our named executive officers | | Management | | For | | For | |
3. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018 | | Management | | For | | For | |
EXPRESS SCRIPTS HOLDING COMPANY
Security | 30219G108 | Meeting Type | Annual |
Ticker Symbol | ESRX | Meeting Date | 10-May-2018 |
Record Date | 13-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Maura C. Breen | | Management | | For | | For | |
1b. | | Election of Director: William J. DeLaney | | Management | | For | | For | |
1c. | | Election of Director: Elder Granger, MD, MG, USA (Retired) | | Management | | For | | For | |
1d. | | Election of Director: Nicholas J. LaHowchic | | Management | | For | | For | |
1e. | | Election of Director: Thomas P. Mac Mahon | | Management | | For | | For | |
1f. | | Election of Director: Kathleen M. Mazzarella | | Management | | For | | For | |
1g. | | Election of Director: Frank Mergenthaler | | Management | | For | | For | |
1h. | | Election of Director: Woodrow A. Myers, Jr., MD | | Management | | For | | For | |
1i. | | Election of Director: Roderick A. Palmore | | Management | | For | | For | |
1j. | | Election of Director: George Paz | | Management | | For | | For | |
1k. | | Election of Director: William L. Roper, MD, MPH | | Management | | For | | For | |
1l. | | Election of Director: Seymour Sternberg | | Management | | For | | For | |
1m. | | Election of Director: Timothy Wentworth | | Management | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accountants for 2018. | | Management | | For | | For | |
3. | | To approve, by non-binding vote, the compensation of the Company’s named executive officers. | | Management | | For | | For | |
4. | | Stockholder proposal requesting the Company to report annually to the Board and stockholders identifying whether there exists a gender pay-gap among the Company’s employees and other related disclosures. | | Shareholder | | Against | | For | |
5. | | Stockholder proposal requesting the Board annually review and publicly report on its cyber risk. | | Shareholder | | Against | | For | |
GALAPAGOS N V
Security | 36315X101 | Meeting Type | Annual |
Ticker Symbol | GLPG | Meeting Date | 24-Apr-2018 |
Record Date | 20-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
2. | | Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2017 and approval of the allocation of the annual result as proposed by the board of directors. | | Management | | For | | N/A | |
5. | | Acknowledgement and approval of the remuneration report. | | Management | | For | | N/A | |
6. | | Release from liability to be granted to the directors and the statutory auditor for the performance of their duties in the course of the financial year ended 31 December 2017. | | Management | | For | | N/A | |
7.1 | | Re-appointment of Dr. Werner Cautreels as director of the Company. | | Management | | For | | N/A | |
7.2 | | Re-appointment of Mr. Howard Rowe as director of the Company. | | Management | | For | | N/A | |
8. | | Remuneration of directors. | | Management | | For | | N/A | |
9. | | Offer of warrants. | | Management | | For | | N/A | |
GALAPAGOS N V
Security | B44170106 | Meeting Type | Annual General Meeting |
Ticker Symbol | GLPG NA | Meeting Date | 24-Apr-2018 |
Record Date | 10-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
CMMT | | MARKET RULES REQUIRE DISCLOSURE OF BENEFICIAL OWNER INFORMATION FOR ALL VOTED-ACCOUNTS. IF AN ACCOUNT HAS MULTIPLE BENEFICIAL OWNERS, YOU WILL NEED TO-PROVIDE THE BREAKDOWN OF EACH BENEFICIAL OWNER NAME, ADDRESS AND SHARE-POSITION TO YOUR CLIENT SERVICE REPRESENTATIVE. THIS INFORMATION IS REQUIRED-IN ORDER FOR YOUR VOTE TO BE LODGED | | Non-Voting | | N/A | | N/A | |
CMMT | | IMPORTANT MARKET PROCESSING REQUIREMENT: A BENEFICIAL OWNER SIGNED POWER OF- ATTORNEY (POA) MAY BE REQUIRED IN ORDER TO LODGE AND EXECUTE YOUR VOTING- INSTRUCTIONS IN THIS MARKET. ABSENCE OF A POA, MAY CAUSE YOUR INSTRUCTIONS TO-BE REJECTED. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT YOUR CLIENT SERVICE- REPRESENTATIVE | | Non-Voting | | N/A | | N/A | |
1 | | ACKNOWLEDGEMENT AND DISCUSSION OF THE ANNUAL REPORT OF THE BOARD OF DIRECTORS- RELATING TO THE NON-CONSOLIDATED AND CONSOLIDATED ANNUAL ACCOUNTS OF THE- COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2017, AND OF THE REPORT-OF THE STATUTORY AUDITOR RELATING TO THE NON- CONSOLIDATED ANNUAL ACCOUNTS OF-THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2017 | | Non-Voting | | N/A | | N/A | |
2 | | ACKNOWLEDGEMENT AND APPROVAL OF THE NON-CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2017 AND APPROVAL OF THE ALLOCATION OF THE ANNUAL RESULT AS PROPOSED BY THE BOARD OF DIRECTORS | | Management | | For | | For | |
3 | | ACKNOWLEDGEMENT AND DISCUSSION OF THE REPORT OF THE STATUTORY AUDITOR-RELATING TO THE CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL-YEAR ENDED ON 31 DECEMBER 2017 | | Non-Voting | | N/A | | N/A | |
4 | | ACKNOWLEDGEMENT AND DISCUSSION OF THE CONSOLIDATED ANNUAL ACCOUNTS OF THE- COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2017 | | Non-Voting | | N/A | | N/A | |
5 | | ACKNOWLEDGEMENT AND APPROVAL OF THE REMUNERATION REPORT | | Management | | For | | For | |
6 | | RELEASE FROM LIABILITY TO BE GRANTED TO THE DIRECTORS AND THE STATUTORY AUDITOR FOR THE PERFORMANCE OF THEIR DUTIES IN THE COURSE OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2017 | | Management | | For | | For | |
7.I | | THE SHAREHOLDERS’ MEETING RESOLVES TO RE- APPOINT DR. WERNER CAUTREELS (RESIDING IN BOSTON, MA, UNITED STATES OF AMERICA) AS DIRECTOR OF THE COMPANY, FOR A PERIOD OF ONE YEAR ENDING IMMEDIATELY AFTER THE ANNUAL SHAREHOLDERS’ MEETING TO BE HELD IN 2019 | | Management | | For | | For | |
7.II | | THE SHAREHOLDERS’ MEETING RESOLVES TO RE- APPOINT MR. HOWARD ROWE (RESIDING IN LONDON, UNITED KINGDOM) AS DIRECTOR OF THE COMPANY, FOR A PERIOD OF FOUR YEARS ENDING IMMEDIATELY AFTER THE ANNUAL SHAREHOLDERS’ MEETING TO BE HELD IN 2022 AND, UPON THE PROPOSAL OF THE BOARD OF DIRECTORS AND IN ACCORDANCE WITH THE ADVICE OF THE COMPANY’S NOMINATION AND REMUNERATION COMMITTEE, TO APPOINT MR. ROWE AS AN INDEPENDENT DIRECTOR AS HE MEETS THE INDEPENDENCE CRITERIA SET FORTH IN ARTICLE 526TER OF THE BELGIAN COMPANIES CODE | | Management | | For | | For | |
8 | | REMUNERATION OF DIRECTORS | | Management | | For | | For | |
9 | | OFFER OF WARRANTS | | Management | | For | | For | |
10 | | MISCELLANEOUS | | Non-Voting | | N/A | | N/A | |
GENOMEDX BIOSCIENCES, INC.
Security | N/A | Meeting Type | Special |
Ticker Symbol | N/A | Meeting Date | 20-Nov-2017 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Authorized Share Structure Amendment Resolution | | Management | | For | | For | |
2. | | Special Rights and Restrictions Resolution | | Management | | For | | For | |
3. | | Class C Preferred Share Issuance Resolution | | Management | | For | | For | |
GENOMEDX BIOSCIENCES, INC.
Security | N/A | Meeting Type | Special |
Ticker Symbol | N/A | Meeting Date | 8-Jan-2018 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Non-shareholders as Proxyholders Resolution | | Management | | For | | For | |
2. | | Special Rights and Restrictions Resolution | | Management | | For | | For | |
GENOMEDX BIOSCIENCES, INC.
Security | N/A | Meeting Type | Special |
Ticker Symbol | N/A | Meeting Date | 4-Feb-2018 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Non-shareholders as Proxyholders Resolution | | Management | | For | | For | |
2. | | Authorized Share Structure Amendment Resolution | | Management | | For | | For | |
3. | | Articles Amendment Resolution | | Management | | For | | For | |
4. | | New Preferred Share Issuance Resolution | | Management | | For | | For | |
GENOMEDX BIOSCIENCES, INC.
Security | N/A | Meeting Type | Special |
Ticker Symbol | N/A | Meeting Date | 31-Mar-2018 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Non-shareholders as Proxyholders Resolution | | Management | | For | | For | |
2. | | Authorized Share Structure Amendment Resolution | | Management | | For | | For | |
3. | | Articles Amendment Resolution | | Management | | For | | For | |
4. | | New Preferred Share Issuance Resolution | | Management | | For | | For | |
GENOMEDX BIOSCIENCES, INC.
Security | N/A | Meeting Type | Special |
Ticker Symbol | N/A | Meeting Date | 9-Jul-2018 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Non-shareholders as Proxyholders Resolution | | Management | | For | | For | |
2. | | Domestication Resolution | | Management | | For | | For | |
GILEAD SCIENCES, INC.
Security | 375558103 | Meeting Type | Annual |
Ticker Symbol | GILD | Meeting Date | 09-May-2018 |
Record Date | 16-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: John F. Cogan, Ph.D. | | Management | | For | | For | |
1b. | | Election of Director: Jacqueline K. Barton, Ph.D. | | Management | | For | | For | |
1c. | | Election of Director: Kelly A. Kramer | | Management | | For | | For | |
1d. | | Election of Director: Kevin E. Lofton | | Management | | For | | For | |
1e. | | Election of Director: John C. Martin, Ph.D. | | Management | | For | | For | |
1f. | | Election of Director: John F. Milligan, Ph.D. | | Management | | For | | For | |
1g. | | Election of Director: Richard J. Whitley, M.D. | | Management | | For | | For | |
1h. | | Election of Director: Gayle E. Wilson | | Management | | For | | For | |
1i. | | Election of Director: Per Wold-Olsen | | Management | | For | | For | |
2. | | To ratify the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. | | Management | | For | | For | |
4. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairman of the Board of Directors be an independent director. | | Shareholder | | Against | | For | |
5. | | To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board take steps to permit stockholder action by written consent. | | Shareholder | | Against | | For | |
HCA HEALTHCARE, INC.
Security | 40412C101 | Meeting Type | Annual |
Ticker Symbol | HCA | Meeting Date | 26-Apr-2018 |
Record Date | 07-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: R. Milton Johnson | | Management | | For | | For | |
1b. | | Election of Director: Robert J. Dennis | | Management | | For | | For | |
1c. | | Election of Director: Nancy-Ann DeParle | | Management | | For | | For | |
1d. | | Election of Director: Thomas F. Frist III | | Management | | For | | For | |
1e. | | Election of Director: William R. Frist | | Management | | For | | For | |
1f. | | Election of Director: Charles O. Holliday, Jr. | | Management | | For | | For | |
1g. | | Election of Director: Ann H. Lamont | | Management | | For | | For | |
1h. | | Election of Director: Geoffrey G. Meyers | | Management | | For | | For | |
1i. | | Election of Director: Michael W. Michelson | | Management | | For | | For | |
1j. | | Election of Director: Wayne J. Riley, M.D. | | Management | | For | | For | |
1k. | | Election of Director: John W. Rowe, M.D. | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2018 | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation | | Management | | For | | For | |
4. | | Advisory vote to approve the frequency of future advisory votes to approve named executive officer compensation | | Management | | 1 Year | | For | |
HUMANA INC.
Security | 444859102 | Meeting Type | Annual |
Ticker Symbol | HUM | Meeting Date | 19-Apr-2018 |
Record Date | 26-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Kurt J. Hilzinger | | Management | | For | | For | |
1b. | | Election of Director: Frank J. Bisignano | | Management | | For | | For | |
1c. | | Election of Director: Bruce D. Broussard | | Management | | For | | For | |
1d. | | Election of Director: Frank A. D’Amelio | | Management | | For | | For | |
1e. | | Election of Director: Karen B. DeSalvo, M.D. | | Management | | For | | For | |
1f. | | Election of Director: W. Roy Dunbar | | Management | | For | | For | |
1g. | | Election of Director: David A. Jones, Jr. | | Management | | For | | For | |
1h. | | Election of Director: William J. McDonald | | Management | | For | | For | |
1i. | | Election of Director: William E. Mitchell | | Management | | For | | For | |
1j. | | Election of Director: David B. Nash, M.D. | | Management | | For | | For | |
1k. | | Election of Director: James J. O’Brien | | Management | | For | | For | |
1l. | | Election of Director: Marissa T. Peterson | | Management | | For | | For | |
2. | | The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm. | | Management | | For | | For | |
3. | | The approval of the compensation of the named executive officers as disclosed in the 2018 proxy statement. | | Management | | For | | For | |
IDEXX LABORATORIES, INC.
Security | 45168D104 | Meeting Type | Annual |
Ticker Symbol | IDXX | Meeting Date | 09-May-2018 |
Record Date | 16-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Bruce L. Claflin | | Management | | For | | For | |
1b. | | Election of Director: Daniel M. Junius | | Management | | For | | For | |
2. | | Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the current fiscal year. | | Management | | For | | For | |
3. | | Approval of the Adoption of the IDEXX Laboratories, Inc. 2018 Incentive Plan. To approve the Company’s 2018 Stock Incentive Plan. | | Management | | For | | For | |
4. | | Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company’s executive compensation. | | Management | | For | | For | |
ILLUMINA, INC.
Security | 452327109 | Meeting Type | Annual |
Ticker Symbol | ILMN | Meeting Date | 23-May-2018 |
Record Date | 29-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Jay T. Flatley | | Management | | For | | For | |
1b. | | Election of Director: John W. Thompson | | Management | | For | | For | |
1c. | | Election of Director: Gary S. Guthart, Ph.D. | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018. | | Management | | For | | For | |
3. | | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | | Management | | For | | For | |
4. | | To approve, on an advisory basis, a stockholder proposal to elect each director annually. | | Shareholder | | Against | | For | |
ILLUMINOSS MEDICAL, INC.
Security | N/A | Meeting Type | Written Consent |
Ticker Symbol | N/A | Meeting Date | 14-Nov-2017 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Sixth Amended and Restated Certificate of Incorporation | | Management | | For | | For | |
2. | | Convertible Note Financing | | Management | | For | | For | |
3. | | Amendment of March 2017 Notes and Warrants | | Management | | For | | For | |
4. | | Anti-Dilution | | Management | | For | | For | |
5. | | General Resolutions | | Management | | For | | For | |
INCYTE CORPORATION
Security | 45337C102 | Meeting Type | Annual |
Ticker Symbol | INCY | Meeting Date | 01-May-2018 |
Record Date | 05-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Director: Julian C. Baker | | Management | | For | | For | |
1.2 | | Election of Director: Jean-Jacques Bienaime | | Management | | For | | For | |
1.3 | | Election of Director: Paul A. Brooke | | Management | | For | | For | |
1.4 | | Election of Director: Paul J. Clancy | | Management | | For | | For | |
1.5 | | Election of Director: Wendy L. Dixon | | Management | | For | | For | |
1.6 | | Election of Director: Jacqualyn A. Fouse | | Management | | For | | For | |
1.7 | | Election of Director: Paul A. Friedman | | Management | | For | | For | |
1.8 | | Election of Director: Herve Hoppenot | | Management | | For | | For | |
2. | | To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers. | | Management | | For | | For | |
3. | | To approve amendments to the Company’s Amended and Restated 2010 Stock Incentive Plan. | | Management | | For | | For | |
4. | | To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2018. | | Management | | For | | For | |
INTUITIVE SURGICAL, INC.
Security | 46120E602 | Meeting Type | Annual |
Ticker Symbol | ISRG | Meeting Date | 19-Apr-2018 |
Record Date | 23-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Craig H. Barratt, Ph.D. | | Management | | For | | For | |
1B. | | Election of Director: Michael A. Friedman, M.D. | | Management | | For | | For | |
1C. | | Election of Director: Gary S. Guthart, Ph.D. | | Management | | For | | For | |
1D. | | Election of Director: Amal M. Johnson | | Management | | For | | For | |
1E. | | Election of Director: Keith R. Leonard, Jr. | | Management | | For | | For | |
1F. | | Election of Director: Alan J. Levy, Ph.D. | | Management | | For | | For | |
1G. | | Election of Director: Jami Dover Nachtsheim | | Management | | For | | For | |
1H. | | Election of Director: Mark J. Rubash | | Management | | For | | For | |
1I. | | Election of Director: Lonnie M. Smith | | Management | | For | | For | |
2. | | To approve, by advisory vote, the compensation of the Company’s Named Executive Officers. | | Management | | For | | For | |
3. | | The ratification of appointment of PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
JOHNSON & JOHNSON
Security | 478160104 | Meeting Type | Annual |
Ticker Symbol | JNJ | Meeting Date | 26-Apr-2018 |
Record Date | 27-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Mary C. Beckerle | | Management | | For | | For | |
1b. | | Election of Director: D. Scott Davis | | Management | | For | | For | |
1c. | | Election of Director: Ian E. L. Davis | | Management | | For | | For | |
1d. | | Election of Director: Jennifer A. Doudna | | Management | | For | | For | |
1e. | | Election of Director: Alex Gorsky | | Management | | For | | For | |
1f. | | Election of Director: Mark B. McClellan | | Management | | For | | For | |
1g. | | Election of Director: Anne M. Mulcahy | | Management | | For | | For | |
1h. | | Election of Director: William D. Perez | | Management | | For | | For | |
1i. | | Election of Director: Charles Prince | | Management | | For | | For | |
1j. | | Election of Director: A. Eugene Washington | | Management | | For | | For | |
1k. | | Election of Director: Ronald A. Williams | | Management | | For | | For | |
2. | | Advisory Vote to Approve Named Executive Officer Compensation | | Management | | For | | For | |
3. | | Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2018 | | Management | | For | | For | |
4. | | Shareholder Proposal - Accounting for Litigation and Compliance in Executive Compensation Performance Measures | | Shareholder | | Against | | For | |
5. | | Shareholder Proposal - Amendment to Shareholder Ability to Call Special Shareholder Meeting | | Shareholder | | Against | | For | |
LTC PROPERTIES, INC.
Security | 502175102 | Meeting Type | Annual |
Ticker Symbol | LTC | Meeting Date | 30-May-2018 |
Record Date | 16-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Director: Boyd W. Hendrickson | | Management | | For | | For | |
1.2 | | Election of Director: James J. Pieczynski | | Management | | For | | For | |
1.3 | | Election of Director: Devra G. Shapiro | | Management | | For | | For | |
1.4 | | Election of Director: Wendy L. Simpson | | Management | | For | | For | |
1.5 | | Election of Director: Timothy J. Triche, M.D. | | Management | | For | | For | |
2. | | Ratification of independent registered public accounting firm. | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
MASIMO CORPORATION
Security | 574795100 | Meeting Type | Annual |
Ticker Symbol | MASI | Meeting Date | 31-May-2018 |
Record Date | 02-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Class II Director: Joe Kiani | | Management | | For | | For | |
1.2 | | Election of Class II Director: Thomas Harkin | | Management | | For | | For | |
2. | | To ratify the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for fiscal year ending December 29, 2018. | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
MCKESSON CORPORATION
Security | 58155Q103 | Meeting Type | Annual |
Ticker Symbol | MCK | Meeting Date | 25-Jul-2018 |
Record Date | 31-May-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: N. Anthony Coles, M.D. | | Management | | For | | For | |
1b. | | Election of Director: John H. Hammergren | | Management | | For | | For | |
1c. | | Election of Director: M. Christine Jacobs | | Management | | For | | For | |
1d. | | Election of Director: Donald R. Knauss | | Management | | For | | For | |
1e. | | Election of Director: Marie L. Knowles | | Management | | For | | For | |
1f. | | Election of Director: Bradley E. Lerman | | Management | | For | | For | |
1g. | | Election of Director: Edward A. Mueller | | Management | | For | | For | |
1h. | | Election of Director: Susan R. Salka | | Management | | For | | For | |
2. | | Ratification of the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending March 31, 2019. | | Management | | For | | For | |
3. | | Advisory vote on executive compensation. | | Management | | For | | For | |
4. | | Shareholder proposal on disclosure of lobbying activities and expenditures. | | Shareholder | | Against | | For | |
5. | | Shareholder proposal on accelerated vesting of equity awards. | | Shareholder | | Against | | For | |
6. | | Shareholder proposal on policy to use GAAP financial metrics for purposes of determining executive compensation. | | Shareholder | | Against | | For | |
7. | | Shareholder proposal on the ownership threshold for calling special meetings of shareholders. | | Shareholder | | Against | | For | |
MEDICAL PROPERTIES TRUST, INC.
Security | 58463J304 | Meeting Type | Annual |
Ticker Symbol | MPW | Meeting Date | 24-May-2018 |
Record Date | 20-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Director: Edward K. Aldag, Jr. | | Management | | For | | For | |
1.2 | | Election of Director: G. Steven Dawson | | Management | | For | | For | |
1.3 | | Election of Director: R. Steven Hamner | | Management | | For | | For | |
1.4 | | Election of Director: Elizabeth N. Pitman | | Management | | For | | For | |
1.5 | | Election of Director: C. Reynolds Thompson, III | | Management | | For | | For | |
1.6 | | Election of Director: D. Paul Sparks, Jr. | | Management | | For | | For | |
1.7 | | Election of Director: Michael G. Stewart | | Management | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | Advisory approval of the Company’s executive compensation. | | Management | | For | | For | |
MEDTRONIC PLC
Security | G5960L103 | Meeting Type | Annual |
Ticker Symbol | MDT | Meeting Date | 08-Dec-2017 |
Record Date | 10-Oct-2017 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | ELECTION OF DIRECTOR: RICHARD H. ANDERSON | | Management | | For | | For | |
1B. | | ELECTION OF DIRECTOR: CRAIG ARNOLD | | Management | | For | | For | |
1C. | | ELECTION OF DIRECTOR: SCOTT C. DONNELLY | | Management | | For | | For | |
1D. | | ELECTION OF DIRECTOR: RANDALL HOGAN III | | Management | | For | | For | |
1E. | | ELECTION OF DIRECTOR: OMAR ISHRAK | | Management | | For | | For | |
1F. | | ELECTION OF DIRECTOR: SHIRLEY A. JACKSON, PH.D. | | Management | | For | | For | |
1G. | | ELECTION OF DIRECTOR: MICHAEL O. LEAVITT | | Management | | For | | For | |
1H. | | ELECTION OF DIRECTOR: JAMES T. LENEHAN | | Management | | For | | For | |
1I. | | ELECTION OF DIRECTOR: ELIZABETH NABEL, M.D. | | Management | | For | | For | |
1J. | | ELECTION OF DIRECTOR: DENISE M. O’LEARY | | Management | | For | | For | |
1K. | | ELECTION OF DIRECTOR: KENDALL J. POWELL | | Management | | For | | For | |
1L. | | ELECTION OF DIRECTOR: ROBERT C. POZEN | | Management | | For | | For | |
2. | | TO RATIFY, IN A NON-BINDING VOTE, THE RE- APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS MEDTRONIC’S INDEPENDENT AUDITOR FOR FISCAL YEAR 2018 AND AUTHORIZE THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT COMMITTEE, TO SET THE AUDITOR’S REMUNERATION. | | Management | | For | | For | |
3. | | TO APPROVE IN A NON-BINDING ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION (A “SAY-ON-PAY” VOTE). | | Management | | For | | For | |
4. | | TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE MEDTRONIC PLC AMENDED AND RESTATED 2013 STOCK AWARD AND INCENTIVE PLAN. | | Management | | For | | For | |
MERCK & CO., INC.
Security | 58933Y105 | Meeting Type | Annual |
Ticker Symbol | MRK | Meeting Date | 22-May-2018 |
Record Date | 28-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Leslie A. Brun | | Management | | For | | For | |
1b. | | Election of Director: Thomas R. Cech | | Management | | For | | For | |
1c. | | Election of Director: Pamela J. Craig | | Management | | For | | For | |
1d. | | Election of Director: Kenneth C. Frazier | | Management | | For | | For | |
1e. | | Election of Director: Thomas H. Glocer | | Management | | For | | For | |
1f. | | Election of Director: Rochelle B. Lazarus | | Management | | For | | For | |
1g. | | Election of Director: John H. Noseworthy | | Management | | For | | For | |
1h. | | Election of Director: Paul B. Rothman | | Management | | For | | For | |
1i. | | Election of Director: Patricia F. Russo | | Management | | For | | For | |
1j. | | Election of Director: Craig B. Thompson | | Management | | For | | For | |
1k. | | Election of Director: Inge G. Thulin | | Management | | For | | For | |
1l. | | Election of Director: Wendell P. Weeks | | Management | | For | | For | |
1m. | | Election of Director: Peter C. Wendell | | Management | | For | | For | |
2. | | Non-binding advisory vote to approve the compensation of our named executive officers. | | Management | | For | | For | |
3. | | Ratification of the appointment of the Company’s independent registered public accounting firm for 2018. | | Management | | For | | For | |
4. | | Shareholder proposal concerning shareholders’ right to act by written consent. | | Shareholder | | Against | | For | |
MILESTONE PHARMACEUTICALS INC.
Security | N/A | Meeting Type | Written Consent |
Ticker Symbol | N/A | Meeting Date | 12-Jun-2018 |
Record Date | N/A | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Acceptance of the Audited Financial Statements of the Corporation for year ended December 31, 2017 | | Management | | For | | For | |
2. | | Election of Directors | | Management | | For | | For | |
3. | | Appointment of Auditors | | Management | | For | | For | |
4. | | Transaction of other Business | | Management | | For | | For | |
MYLAN N.V.
Security | N59465109 | Meeting Type | Annual |
Ticker Symbol | MYL | Meeting Date | 29-Jun-2018 |
Record Date | 01-Jun-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Appointment of Director: Heather Bresch | | Management | | For | | For | |
1B. | | Appointment of Director: Hon. Robert J. Cindrich | | Management | | For | | For | |
1C. | | Appointment of Director: Robert J. Coury | | Management | | For | | For | |
1D. | | Appointment of Director: JoEllen Lyons Dillon | | Management | | For | | For | |
1E. | | Appointment of Director: Neil Dimick, C.P.A. | | Management | | For | | For | |
1F. | | Appointment of Director: Melina Higgins | | Management | | For | | For | |
1G. | | Appointment of Director: Harry A. Korman | | Management | | For | | For | |
1H. | | Appointment of Director: Rajiv Malik | | Management | | For | | For | |
1I. | | Appointment of Director: Mark W. Parrish | | Management | | For | | For | |
1J. | | Appointment of Director: Pauline van der Meer Mohr | | Management | | For | | For | |
1K. | | Appointment of Director: Randall L. (Pete) Vanderveen, Ph.D. | | Management | | For | | For | |
1L. | | Appointment of Director: Sjoerd S. Vollebregt | | Management | | For | | For | |
2. | | Approval, on an advisory basis, of the compensation of the named executive officers of the Company | | Management | | For | | For | |
3. | | Adoption of the Dutch annual accounts for fiscal year 2017 | | Management | | For | | For | |
4. | | Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2018 | | Management | | For | | For | |
5. | | Instruction to Deloitte Accountants B.V. for the audit of the Company’s Dutch statutory annual accounts for fiscal year 2018 | | Management | | For | | For | |
6. | | Authorization of the Board to acquire shares in the capital of the Company | | Management | | For | | For | |
NATERA, INC.
Security | 632307104 | Meeting Type | Annual |
Ticker Symbol | NTRA | Meeting Date | 16-May-2018 |
Record Date | 26-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Roelof F. Botha | | | | For | | For | |
| | 2 | Todd Cozzens | | | | For | | For | |
| | 3 | Matthew Rabinowitz | | | | For | | For | |
2. | | Proposal to ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
NEUROCRINE BIOSCIENCES, INC.
Security | 64125C109 | Meeting Type | Annual |
Ticker Symbol | NBIX | Meeting Date | 24-May-2018 |
Record Date | 29-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | William H Rastetter PhD | | | | For | | For | |
| | 2 | George J. Morrow | | | | For | | For | |
2. | | Advisory vote to approve the compensation paid to the Company’s named executive officers. | | Management | | For | | For | |
3. | | To approve an amendment to the Company’s 2011 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder from 17,000,000 to 19,000,000. | | Management | | For | | For | |
4. | | To approve the Company’s 2018 Employee Stock Purchase Plan. | | Management | | Against | | Against | |
5. | | To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
NEW SENIOR INVESTMENT GROUP INC.
Security | 648691103 | Meeting Type | Annual |
Ticker Symbol | SNR | Meeting Date | 11-Jun-2018 |
Record Date | 19-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Virgis W. Colbert | | | | For | | For | |
| | 2 | C. van der H. Holstein | | | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for New Senior Investment Group Inc. for fiscal year 2018. | | Management | | For | | For | |
3. | | Non-binding stockholder proposal to adopt “majority voting” in uncontested elections of directors. | | Shareholder | | Abstain | | N/A | |
OMEGA HEALTHCARE INVESTORS, INC.
Security | 681936100 | Meeting Type | Annual |
Ticker Symbol | OHI | Meeting Date | 08-Jun-2018 |
Record Date | 23-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Kapila K. Anand | | | | For | | For | |
| | 2 | Craig M. Bernfield | | | | For | | For | |
| | 3 | Norman R. Bobins | | | | For | | For | |
| | 4 | Craig R. Callen | | | | For | | For | |
| | 5 | Barbara B. Hill | | | | For | | For | |
| | 6 | Edward Lowenthal | | | | For | | For | |
| | 7 | Ben W. Perks | | | | For | | For | |
| | 8 | C. Taylor Pickett | | | | For | | For | |
| | 9 | Stephen D. Plavin | | | | For | | For | |
2. | | Ratification of Independent Auditors Ernst & Young LLP. | | Management | | For | | For | |
3. | | Approval, on an Advisory Basis, of Executive Compensation. | | Management | | For | | For | |
4. | | Approval of 2018 Stock Incentive Plan. | | Management | | For | | For | |
PFIZER INC.
Security | 717081103 | Meeting Type | Annual |
Ticker Symbol | PFE | Meeting Date | 26-Apr-2018 |
Record Date | 27-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Dennis A. Ausiello | | Management | | For | | For | |
1b. | | Election of Director: Ronald E. Blaylock | | Management | | For | | For | |
1c. | | Election of Director: Albert Bourla | | Management | | For | | For | |
1d. | | Election of Director: W. Don Cornwell | | Management | | For | | For | |
1e. | | Election of Director: Joseph J. Echevarria | | Management | | For | | For | |
1f. | | Election of Director: Helen H. Hobbs | | Management | | For | | For | |
1g. | | Election of Director: James M. Kilts | | Management | | For | | For | |
1h. | | Election of Director: Dan R. Littman | | Management | | For | | For | |
1i. | | Election of Director: Shantanu Narayen | | Management | | For | | For | |
1j. | | Election of Director: Suzanne Nora Johnson | | Management | | For | | For | |
1k. | | Election of Director: Ian C. Read | | Management | | For | | For | |
1l. | | Election of Director: James C. Smith | | Management | | For | | For | |
2. | | Ratify the selection of KPMG LLP as independent registered public accounting firm for 2018 | | Management | | For | | For | |
3. | | 2018 Advisory approval of executive compensation | | Management | | For | | For | |
4. | | Approval of the Pfizer Inc. French Sub-Plan under the 2014 Stock Plan | | Management | | For | | For | |
5. | | Shareholder proposal regarding right to act by written consent | | Shareholder | | Against | | For | |
6. | | Shareholder proposal regarding independent chair policy | | Shareholder | | Against | | For | |
7. | | Shareholder proposal regarding report on lobbying activities | | Shareholder | | Against | | For | |
PHYSICIANS REALTY TRUST
Security | 71943U104 | Meeting Type | Annual |
Ticker Symbol | DOC | Meeting Date | 03-May-2018 |
Record Date | 01-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | John T. Thomas | | | | For | | For | |
| | 2 | Tommy G. Thompson | | | | For | | For | |
| | 3 | Stanton D. Anderson | | | | For | | For | |
| | 4 | Mark A. Baumgartner | | | | For | | For | |
| | 5 | Albert C. Black, Jr. | | | | For | | For | |
| | 6 | William A. Ebinger MD | | | | For | | For | |
| | 7 | Pamela J. Kessler | | | | For | | For | |
| | 8 | Richard A. Weiss | | | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the accompanying proxy statement. | | Management | | For | | For | |
PIERIS PHARMACEUTICALS, INC.
Security | 720795103 | Meeting Type | Annual |
Ticker Symbol | PIRS | Meeting Date | 24-Jul-2018 |
Record Date | 25-May-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Christopher P. Kiritsy | | | | For | | For | |
| | 2 | Jean-Pierre Bizzari | | | | For | | For | |
2. | | Approve the Company’s 2018 Employee, Director and Consultant Equity Incentive Plan. | | Management | | For | | For | |
3. | | Approve the Company’s 2018 Employee Stock Purchase Plan. | | Management | | For | | For | |
4. | | Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
PUMA BIOTECHNOLOGY, INC.
Security | 74587V107 | Meeting Type | Annual |
Ticker Symbol | PBYI | Meeting Date | 12-Jun-2018 |
Record Date | 20-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Alan H. Auerbach | | | | For | | For | |
| | 2 | Michael P. Miller | | | | For | | For | |
| | 3 | Jay M. Moyes | | | | For | | For | |
| | 4 | Adrian M. Senderowicz | | | | For | | For | |
| | 5 | Troy E. Wilson | | | | For | | For | |
| | 6 | Frank E. Zavrl | | | | For | | For | |
2. | | Ratification of the selection of KPMG LLP as independent registered public accounting firm of Puma Biotechnology, Inc. for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.’s named executive officers. | | Management | | For | | For | |
4. | | Advisory (non-binding) vote to approve the frequency of future votes on Puma Biotechnology, Inc.’s executive compensation. | | Management | | 1 Year | | For | |
REGENERON PHARMACEUTICALS, INC.
Security | 75886F107 | Meeting Type | Annual |
Ticker Symbol | REGN | Meeting Date | 08-Jun-2018 |
Record Date | 12-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Director: Arthur F. Ryan | | Management | | For | | For | |
1.2 | | Election of Director: George L. Sing | | Management | | For | | For | |
1.3 | | Election of Director: Marc Tessier-Lavigne | | Management | | For | | For | |
2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
SABRA HEALTH CARE REIT, INC.
Security | 78573L106 | Meeting Type | Special |
Ticker Symbol | SBRA | Meeting Date | 15-Aug-2017 |
Record Date | 29-Jun-2017 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | TO APPROVE THE ISSUANCE OF SABRA HEALTH CARE REIT, INC. (“SABRA”) COMMON STOCK IN CONNECTION WITH THE MERGER (THE “MERGER”) OF CARE CAPITAL PROPERTIES, INC., A DELAWARE CORPORATION (“CCP”), WITH AND INTO PR SUB, LLC, A DELAWARE LIMITED LIABILITY COMPANY AND WHOLLY-OWNED SUBSIDIARY OF SABRA (“MERGER SUB”), WITH MERGER SUB CONTINUING AS THE SURVIVING COMPANY IN THE MERGER, PURSUANT TO THE AGREEMENT AND PLAN OF MERGER, DATED AS OF MAY 7, 2017, BY AND AMONG ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL). | | Management | | For | | For | |
2. | | TO APPROVE THE ADJOURNMENT OF THE SABRA SPECIAL MEETING FROM TIME TO TIME, IF NECESSARY OR APPROPRIATE, INCLUDING TO SOLICIT ADDITIONAL PROXIES IN FAVOR OF THE SABRA COMMON STOCK ISSUANCE PROPOSAL IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF SUCH ADJOURNMENT TO APPROVE SUCH PROPOSAL. | | Management | | For | | For | |
SABRA HEALTH CARE REIT, INC.
Security | 78573L106 | Meeting Type | Annual |
Ticker Symbol | SBRA | Meeting Date | 21-Jun-2018 |
Record Date | 16-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Craig A. Barbarosh | | Management | | For | | For | |
1b. | | Election of Director: Robert A. Ettl | | Management | | For | | For | |
1c. | | Election of Director: Michael J. Foster | | Management | | For | | For | |
1d. | | Election of Director: Ronald G. Geary | | Management | | For | | For | |
1e. | | Election of Director: Raymond J. Lewis | | Management | | For | | For | |
1f. | | Election of Director: Jeffrey A. Malehorn | | Management | | For | | For | |
1g. | | Election of Director: Richard K. Matros | | Management | | For | | For | |
1h. | | Election of Director: Milton J. Walters | | Management | | For | | For | |
2. | | Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | Approval, on an advisory basis, of the compensation of Sabra’s named executive officers. | | Management | | For | | For | |
SAGE THERAPEUTICS, INC.
Security | 78667J108 | Meeting Type | Annual |
Ticker Symbol | SAGE | Meeting Date | 06-Jun-2018 |
Record Date | 09-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Geno Germano | | | | For | | For | |
| | 2 | Steven Paul | | | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | Approve, on an advisory basis, the compensation of the named executive officers. | | Management | | For | | For | |
SAREPTA THERAPEUTICS INC.
Security | 803607100 | Meeting Type | Annual |
Ticker Symbol | SRPT | Meeting Date | 06-Jun-2018 |
Record Date | 11-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A | | ELECTION OF GROUP I DIRECTOR: Michael W. Bonney | | Management | | For | | For | |
1B | | ELECTION OF GROUP I DIRECTOR: Douglas S. Ingram | | Management | | For | | For | |
1C | | ELECTION OF GROUP I DIRECTOR: Hans Wigzell, M.D., Ph.D. | | Management | | For | | For | |
2. | | ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION | | Management | | For | | For | |
3. | | APPROVAL OF THE COMPANY’S 2018 EQUITY INCENTIVE PLAN | | Management | | For | | For | |
4. | | RATIFICATION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2018 | | Management | | For | | For | |
SEATTLE GENETICS, INC.
Security | 812578102 | Meeting Type | Annual |
Ticker Symbol | SGEN | Meeting Date | 18-May-2018 |
Record Date | 22-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | DIRECTOR | | Management | | | | | |
| | 1 | Clay B. Siegall | | | | For | | For | |
| | 2 | Felix Baker | | | | For | | For | |
| | 3 | Nancy A. Simonian | | | | For | | For | |
2. | | To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
3. | | To approve the amendment and restatement of the Seattle Genetics, Inc. Amended and Restated 2007 Equity and Incentive Plan to, among other changes, increase the aggregate number of shares of common stock authorized for issuance thereunder by 6,000,000. | | Management | | For | | For | |
4. | | Advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement. | | Management | | For | | For | |
SENIOR HOUSING PROPERTIES TRUST
Security | 81721M109 | Meeting Type | Annual |
Ticker Symbol | SNH | Meeting Date | 22-May-2018 |
Record Date | 01-Feb-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Trustee: Lisa Harris Jones (for Independent Trustee in Class I) | | Management | | For | | For | |
1.2 | | Election of Trustee: Jennifer B. Clark (for Managing Trustee in Class I) | | Management | | For | | For | |
2. | | Advisory vote to approve executive compensation. | | Management | | For | | For | |
3. | | Ratification of the appointment of Ernst & Young LLP as independent auditors to serve for the 2018 fiscal year. | | Management | | For | | For | |
STERIS PLC
Security | G84720104 | Meeting Type | Annual |
Ticker Symbol | STE | Meeting Date | 31-Jul-2018 |
Record Date | 30-May-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Re-election of Director: Richard C. Breeden | | Management | | For | | For | |
1b. | | Re-election of Director: Cynthia L. Feldmann | | Management | | For | | For | |
1c. | | Re-election of Director: Dr. Jacqueline B. Kosecoff | | Management | | For | | For | |
1d. | | Re-election of Director: David B. Lewis | | Management | | For | | For | |
1e. | | Re-election of Director: Sir Duncan K. Nichol | | Management | | For | | For | |
1f. | | Re-election of Director: Walter M Rosebrough, Jr. | | Management | | For | | For | |
1g. | | Re-election of Director: Dr. Nirav R. Shah | | Management | | For | | For | |
1h. | | Re-election of Director: Dr. Mohsen M. Sohi | | Management | | For | | For | |
1i. | | Re-election of Director: Dr. Richard M. Steeves | | Management | | For | | For | |
1j. | | Re-election of Director: Loyal W. Wilson | | Management | | For | | For | |
1k. | | Re-election of Director: Dr. Michael B. Wood | | Management | | For | | For | |
2. | | To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2019. | | Management | | For | | For | |
3. | | To appoint Ernst & Young LLP as the Company’s U.K. statutory auditor under the Act to hold office until the conclusion of the Company’s next Annual General Meeting. | | Management | | For | | For | |
4. | | To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young LLP as the Company’s U.K. statutory auditor. | | Management | | For | | For | |
5. | | To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s Proxy Statement dated June 12, 2018. | | Management | | For | | For | |
6. | | To approve, on a non-binding advisory basis, the Director Remuneration Report for the period ended March 31, 2018 contained within the Company’s U.K. annual report and accounts for the year ended March 31, 2018. | | Management | | For | | For | |
STRYKER CORPORATION
Security | 863667101 | Meeting Type | Annual |
Ticker Symbol | SYK | Meeting Date | 02-May-2018 |
Record Date | 05-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Mary K. Brainerd | | Management | | For | | For | |
1b. | | Election of Director: Srikant M. Datar, Ph.D. | | Management | | For | | For | |
1c. | | Election of Director: Roch Doliveux, DVM | | Management | | For | | For | |
1d. | | Election of Director: Louise L. Francesconi | | Management | | For | | For | |
1e. | | Election of Director: Allan C. Golston (Lead Independent Director) | | Management | | For | | For | |
1f. | | Election of Director: Kevin A. Lobo (Chairman of the Board) | | Management | | For | | For | |
1g. | | Election of Director: Sherilyn S. McCoy | | Management | | For | | For | |
1h. | | Election of Director: Andrew K. Silvernail | | Management | | For | | For | |
1i. | | Election of Director: Ronda E. Stryker | | Management | | For | | For | |
1j. | | Election of Director: Rajeev Suri | | Management | | For | | For | |
2. | | Ratify appointment of Ernst & Young LLP as our independent registered public accounting firm for 2018. | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
TELEFLEX INCORPORATED
Security | 879369106 | Meeting Type | Annual |
Ticker Symbol | TFX | Meeting Date | 04-May-2018 |
Record Date | 05-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Candace H. Duncan (For term ending in 2021) | | Management | | For | | For | |
1b. | | Election of Director: Liam J. Kelly (For term ending in 2021) | | Management | | For | | For | |
1c. | | Election of Director: Stephen K. Klasko (For term ending in 2021) | | Management | | For | | For | |
1d. | | Election of Director: Stuart A. Randle (For term ending in 2021) | | Management | | For | | For | |
1e. | | Election of Director: Andrew A. Krakauer (For term ending in 2019) | | Management | | For | | For | |
2. | | Approval, on an advisory basis, of named executive officer compensation. | | Management | | For | | For | |
3. | | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2018. | | Management | | For | | For | |
TENET HEALTHCARE CORPORATION
Security | 88033G407 | Meeting Type | Annual |
Ticker Symbol | THC | Meeting Date | 03-May-2018 |
Record Date | 29-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A | | Election of Director: Ronald A. Rittenmeyer | | Management | | For | | For | |
1B | | Election of Director: J. Robert Kerrey | | Management | | For | | For | |
1C | | Election of Director: James L. Bierman | | Management | | For | | For | |
1D | | Election of Director: Richard W. Fisher | | Management | | For | | For | |
1E | | Election of Director: Brenda J. Gaines | | Management | | For | | For | |
1F | | Election of Director: Edward A. Kangas | | Management | | For | | For | |
1G | | Election of Director: Richard J. Mark | | Management | | For | | For | |
1H | | Election of Director: Tammy Romo | | Management | | For | | For | |
2 | | Proposal to approve, on an advisory basis, the company’s executive compensation. | | Management | | For | | For | |
3 | | Proposal to ratify the selection of Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2018 | | Management | | For | | For | |
4 | | Shareholder proposal to urge the Board to adopt a policy that the chairman of the Board be an independent director. | | Shareholder | | For | | Against | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Security | 881624209 | Meeting Type | Annual |
Ticker Symbol | TEVA | Meeting Date | 05-Jun-2018 |
Record Date | 26-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Director: Rosemary A. Crane | | Management | | For | | For | |
1.2 | | Election of Director: Gerald M. Lieberman | | Management | | For | | For | |
1.3 | | Election of Director: Professor Ronit Satchi-Fainaro | | Management | | For | | For | |
2. | | To approve, on a non-binding advisory basis, the compensation for Teva’s named executive officers. | | Management | | For | | For | |
3. | | To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva’s named executive officers every one, two or three years. | | Management | | 1 Year | | For | |
4. | | To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva’s independent registered public accounting firm until the 2019 annual meeting of shareholders. | | Management | | For | | For | |
5. | | To approve an amendment and restatement of Teva’s 2008 Employee Stock Purchase Plan for U.S. Employees. | | Management | | For | | For | |
THE MEDICINES COMPANY
Security | 584688105 | Meeting Type | Annual |
Ticker Symbol | MDCO | Meeting Date | 31-May-2018 |
Record Date | 13-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Alexander J. Denner | | Management | | For | | For | |
1B. | | Election of Director: Fredric N. Eshelman | | Management | | For | | For | |
1C. | | Election of Director: Geno J. Germano | | Management | | For | | For | |
1D. | | Election of Director: John C. Kelly | | Management | | For | | For | |
1E. | | Election of Director: Clive A. Meanwell | | Management | | For | | For | |
1F. | | Election of Director: Paris Panayiotopoulos | | Management | | For | | For | |
1G. | | Election of Director: Sarah J. Schlesinger | | Management | | For | | For | |
2. | | Approve an amendment to our 2013 stock incentive plan in order to increase the number of shares of common stock authorized for issuance under the plan by 5,000,000 shares. | | Management | | For | | For | |
3. | | Approve, in an advisory vote, the compensation of our named executive officers as presented in the proxy statement. | | Management | | For | | For | |
4. | | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018. | | Management | | For | | For | |
THE RMR GROUP INC.
Security | 74967R106 | Meeting Type | Annual |
Ticker Symbol | RMR | Meeting Date | 28-Mar-2018 |
Record Date | 17-Jan-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Director: Ann Logan | | Management | | For | | For | |
1.2 | | Election of Director: Rosen Plevneliev | | Management | | For | | For | |
1.3 | | Election of Director: Adam D. Portnoy | | Management | | For | | For | |
1.4 | | Election of Director: Barry M. Portnoy | | Management | | For | | For | |
1.5 | | Election of Director: Walter C. Watkins, Jr. | | Management | | For | | For | |
2. | | Ratification of the appointment of Ernst & Young LLP as independent auditors to serve for the 2018 fiscal year. | | Management | | For | | For | |
THERMO FISHER SCIENTIFIC INC.
Security | 883556102 | Meeting Type | Annual |
Ticker Symbol | TMO | Meeting Date | 23-May-2018 |
Record Date | 28-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Marc N. Casper | | Management | | For | | For | |
1B. | | Election of Director: Nelson J. Chai | | Management | | For | | For | |
1C. | | Election of Director: C. Martin Harris | | Management | | For | | For | |
1D. | | Election of Director: Tyler Jacks | | Management | | For | | For | |
1E. | | Election of Director: Judy C. Lewent | | Management | | For | | For | |
1F. | | Election of Director: Thomas J. Lynch | | Management | | For | | For | |
1G. | | Election of Director: Jim P. Manzi | | Management | | For | | For | |
1H. | | Election of Director: Lars R. Sorensen | | Management | | For | | For | |
1I. | | Election of Director: Scott M. Sperling | | Management | | For | | For | |
1J. | | Election of Director: Elaine S. Ullian | | Management | | For | | For | |
1K. | | Election of Director: Dion J. Weisler | | Management | | For | | For | |
2. | | An advisory vote to approve named executive officer compensation. | | Management | | For | | For | |
3. | | Ratification of the Audit Committee’s selection of PricewaterhouseCoopers LLP as the Company’s independent auditors for 2018. | | Management | | For | | For | |
UNIQURE N.V.
Security | N90064101 | Meeting Type | Annual |
Ticker Symbol | QURE | Meeting Date | 13-Jun-2018 |
Record Date | 16-May-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1. | | Resolution to adopt the 2017 annual accounts and treatment of the results. | | Management | | For | | For | |
2. | | Resolution to discharge liability of the members of the Board for their management. | | Management | | For | | For | |
3a. | | Appointment of Philip Astley-Sparke as non-executive director. | | Management | | For | | For | |
3b. | | Appointment of Robert Gut as non-executive director. | | Management | | For | | For | |
3c. | | Appointment of David Meek as non-executive director. | | Management | | For | | For | |
4. | | Amendment to the 2014 Restated Plan. | | Management | | For | | For | |
5. | | Resolution to designate the Board as the competent body to issue ordinary shares and options and to exclude preemptive rights under the 2014 Restated Plan. | | Management | | For | | For | |
6. | | Approval of the employee share purchase plan. | | Management | | For | | For | |
7. | | Resolution to redesignate the Board as the competent body to issue ordinary shares and options and to limit or exclude pre-emptive rights. | | Management | | For | | For | |
8. | | Authorization of the Board to repurchase ordinary shares. | | Management | | For | | For | |
9. | | Resolution to reappoint PricewaterhouseCoopers Accountants N.V. as auditor of the Company for the 2018 financial year ending at the close of the Annual General Meeting. | | Management | | For | | For | |
UNITEDHEALTH GROUP INCORPORATED
Security | 91324P102 | Meeting Type | Annual |
Ticker Symbol | UNH | Meeting Date | 04-Jun-2018 |
Record Date | 10-Apr-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: William C. Ballard, Jr. | | Management | | For | | For | |
1b. | | Election of Director: Richard T. Burke | | Management | | For | | For | |
1c. | | Election of Director: Timothy P. Flynn | | Management | | For | | For | |
1d. | | Election of Director: Stephen J. Hemsley | | Management | | For | | For | |
1e. | | Election of Director: Michele J. Hooper | | Management | | For | | For | |
1f. | | Election of Director: F. William McNabb III | | Management | | For | | For | |
1g. | | Election of Director: Valerie C. Montgomery Rice, M.D. | | Management | | For | | For | |
1h. | | Election of Director: Glenn M. Renwick | | Management | | For | | For | |
1i. | | Election of Director: Kenneth I. Shine, M.D. | | Management | | For | | For | |
1j. | | Election of Director: David S. Wichmann | | Management | | For | | For | |
1k. | | Election of Director: Gail R. Wilensky, Ph.D. | | Management | | For | | For | |
2. | | Advisory approval of the Company’s executive compensation. | | Management | | For | | For | |
3. | | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2018. | | Management | | For | | For | |
VENTAS, INC.
Security | 92276F100 | Meeting Type | Annual |
Ticker Symbol | VTR | Meeting Date | 15-May-2018 |
Record Date | 16-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1A. | | Election of Director: Melody C. Barnes | | Management | | For | | For | |
1B. | | Election of Director: Debra A. Cafaro | | Management | | For | | For | |
1C. | | Election of Director: Jay M. Gellert | | Management | | For | | For | |
1D. | | Election of Director: Richard I. Gilchrist | | Management | | For | | For | |
1E. | | Election of Director: Matthew J. Lustig | | Management | | For | | For | |
1F. | | Election of Director: Roxanne M. Martino | | Management | | For | | For | |
1G. | | Election of Director: Walter C. Rakowich | | Management | | For | | For | |
1H. | | Election of Director: Robert D. Reed | | Management | | For | | For | |
1I. | | Election of Director: James D. Shelton | | Management | | For | | For | |
2. | | Ratification of the selection of KPMG LLP as the independent registered public accounting firm for fiscal year 2018. | | Management | | For | | For | |
3. | | Advisory vote to approve our executive compensation. | | Management | | For | | For | |
VERTEX PHARMACEUTICALS INCORPORATED
Security | 92532F100 | Meeting Type | Annual |
Ticker Symbol | VRTX | Meeting Date | 17-May-2018 |
Record Date | 29-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1.1 | | Election of Class I Director: Sangeeta N. Bhatia | | Management | | For | | For | |
1.2 | | Election of Class I Director: Jeffrey M. Leiden | | Management | | For | | For | |
1.3 | | Election of Class I Director: Bruce I. Sachs | | Management | | For | | For | |
2. | | Amendments to our charter and by-laws to eliminate supermajority provisions. | | Management | | For | | For | |
3. | | Amendment and restatement of our 2013 Stock and Option Plan, to among other things, increase the number of shares available under the plan by 8.0 million shares. | | Management | | For | | For | |
4. | | Ratification of Ernst & Young LLP as our Independent Registered Public Accounting firm for the year ending December 31, 2018. | | Management | | For | | For | |
5. | | Advisory vote on named executive officer compensation. | | Management | | For | | For | |
6. | | Shareholder proposal, if properly presented at the meeting, requesting that we prepare a report on the risks to us of rising drug prices. | | Shareholder | | Against | | For | |
7. | | Shareholder proposal, if properly presented at the meeting, requesting that we prepare a report on our policies and activities with respect to lobbying. | | Shareholder | | Against | | For | |
WRIGHT MEDICAL GROUP N V
Security | N96617118 | Meeting Type | Annual |
Ticker Symbol | WMGI | Meeting Date | 29-Jun-2018 |
Record Date | 01-Jun-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Appointment of Robert J. Palmisano for executive director. Mark “For” to appoint Palmisano. | | Management | | For | | For | |
1b. | | Appointment of David D. Stevens for non-executive director. Mark “For” to appoint Stevens. | | Management | | For | | For | |
1c. | | Appointment of Gary D. Blackford for non-executive director. Mark “For” to appoint Blackford. | | Management | | For | | For | |
1d. | | Appointment of J. Patrick Mackin for non-executive director. Mark “For” to appoint Mackin. | | Management | | For | | For | |
1e. | | Appointment of John L. Miclot for non-executive director. Mark “For” to appoint Miclot. | | Management | | For | | For | |
1f. | | Appointment of Kevin C. O’Boyle for non-executive director. Mark “For” to appoint O’Boyle. | | Management | | For | | For | |
1g. | | Appointment of Amy S. Paul for non-executive director. Mark “For” to appoint Paul. | | Management | | For | | For | |
1h. | | Appointment of Richard F. Wallman for non-executive director. Mark “For” to appoint Wallman. | | Management | | For | | For | |
1i. | | Appointment of Elizabeth H. Weatherman for non- executive director. Mark “For” to appoint Weatherman. | | Management | | For | | For | |
2. | | Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 30, 2018. | | Management | | For | | For | |
3. | | Appointment of KPMG N.V. as the auditor for our Dutch statutory annual accounts for the fiscal year ending December 30, 2018. | | Management | | For | | For | |
4. | | Adoption of our Dutch statutory annual accounts for the fiscal year ended December 31, 2017. | | Management | | For | | For | |
5. | | Release of each member of our board of directors from liability with respect to the exercise of his or her duties during the fiscal year ended December 31, 2017. | | Management | | For | | For | |
6. | | Extension of the authority of our board of directors to repurchase up to 10% of our issued share capital (including depositary receipts issued for our shares) until December 29, 2019 on the open market, through privately negotiated transactions or in one or more self- tender offers for a price per share (or depositary receipt) not less than the nominal value of a share and not higher than 110% of the market price of a share (or depositary receipt) at the time of the transaction. | | Management | | For | | For | |
7. | | Approval, on an advisory basis, of our executive compensation. | | Management | | For | | For | |
ZIMMER BIOMET HOLDINGS, INC.
Security | 98956P102 | Meeting Type | Annual |
Ticker Symbol | ZBH | Meeting Date | 15-May-2018 |
Record Date | 16-Mar-2018 | | |
Item | | Proposal | | Proposed
by | | Vote | | For/Against
Management | |
1a. | | Election of Director: Christopher B. Begley | | Management | | For | | For | |
1b. | | Election of Director: Betsy J. Bernard | | Management | | For | | For | |
1c. | | Election of Director: Gail K. Boudreaux | | Management | | For | | For | |
1d. | | Election of Director: Michael J. Farrell | | Management | | For | | For | |
1e. | | Election of Director: Larry C. Glasscock | | Management | | For | | For | |
1f. | | Election of Director: Robert A. Hagemann | | Management | | For | | For | |
1g. | | Election of Director: Bryan C. Hanson | | Management | | For | | For | |
1h. | | Election of Director: Arthur J. Higgins | | Management | | For | | For | |
1i. | | Election of Director: Michael W. Michelson | | Management | | For | | For | |
2. | | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2018 | | Management | | For | | For | |
3. | | Advisory vote to approve named executive officer compensation (Say on Pay) | | Management | | For | | For | |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) | Tekla Healthcare Opportunites Fund | |
| | |
By (Signature and Title)* | | |
| | |
| /s/ Daniel R. Omstead | |
| (Daniel R. Omstead, President) | |
| | |
Date | 8/20/18 | |
| | | | |
*Print the name and title of each signing officer under his or her signature.
2
